未登录

B

Benjamin Davis

oklahoma state university - tulsa

H指数:28

被引数:4,273

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Flight Testing a Trajectory Control System on a Subscale Transitioning VTOL Aircraft

在缩比过渡垂直起降（VTOL）飞行器上测试轨迹控制系统

JOURNAL OF GUIDANCE CONTROL AND DYNAMICS

IF2.8

2025-10-010

PRE

Organ-specific features of human kidney lymphatics are disrupted in chronic transplant rejection

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2025-09-162

OA

Jafree, Daniyal J.; Stewart, Benjamin J.; Price, Karen L.; Kolatsi-Joannou, Maria; Laroche, Camille; Mohidin, Barian; Davis, Benjamin; Mitchell, Hannah; Russell, Lauren G.; del Rey, Lucia Marinas; Wang, Chun Jing; Mason, William J.; Lee, Byung Il; Heptinstall, Lauren; Subramanian, Ayshwarya; Pomeranz, Gideon; Moulding, Dale; Wilson, Laura; Wickenden, Tahmina; Malik, Saif N.; Holroyd, Natalie; Walsh, Claire L.; Chandler, Jennifer C.; Cao, Kevin X.; Winyard, Paul J. D.; Woolf, Adrian S.; Busche, Marc Aurel; Walker-Samuel, Simon; Walker, Lucy S. K.; Crompton, Tessa; Scambler, Peter J.; Motallebzadeh, Reza; Clatworthy, Menna R.; Long, David A.

Curcumin nanoparticles: Neuroprotection in Alzheimer's disease assessed through the eye

姜黄素纳米颗粒：通过眼睛评估阿尔茨海默病中的神经保护作用

ACTA OPHTHALMOLOGICA

IF2.8

2025-01-190

PRE

Effects of oral and intranasal resveratrol nanoparticle administration on neurodegeneration and neuronal dysfunction in a model of multiple sclerosis

ACTA OPHTHALMOLOGICA

IF2.8

2024-01-180

OA

Nanoparticles Enhance Solubility and Neuroprotective Effects of Resveratrol in Demyelinating Disease

NEUROTHERAPEUTICS

IF6.9

2023-07-018

OAAI

Resveratrol nanoparticles are neuroprotective in a model of Alzheimer's disease

ACTA OPHTHALMOLOGICA

IF2.8

2022-12-200

PRE

Glaucoma rose plots: redesigning circumpapillary progression analysis

ACTA OPHTHALMOLOGICA

IF2.8

2022-01-030

PRE

Resveratrol nanoparticles reduce retinal ganglion cell loss in glaucoma

ACTA OPHTHALMOLOGICA

IF2.8

2022-01-032

PRE

Resveratrol nanoparticles are neuroprotective in a model of multiple sclerosis

ACTA OPHTHALMOLOGICA

IF2.8

2021-01-170

PRE

A novel retinal ganglion cell quantification tool based on deep learning

SCIENTIFIC REPORTS

IF3.9

2021-01-1227

OAAI

Dynamic changes in cell size and corresponding cell fate after optic nerve injury

SCIENTIFIC REPORTS

IF3.9

2020-12-104

OAAI

Tightening the retinal glia limitans attenuates neuroinflammation after optic nerve injury

IF5.1

2020-07-0912

OAAI

Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration

SCIENTIFIC REPORTS

IF3.9

2020-02-2531

OAAI

Longitudinal morphological assessment of macular changes in glaucoma

ACTA OPHTHALMOLOGICA

IF2.8

2019-12-190

PRE

Curry to treat Alzheimers disease?

ACTA OPHTHALMOLOGICA

IF2.8

2019-12-190

PRE

Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma

IF5.1

2019-09-1049

OAAI

Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension (vol 36, pg 114, 2017)

IF4.5

2019-07-010

OAAI

Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease

SCIENTIFIC REPORTS

IF3.9

2018-07-2384

OAAI

Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes

NEUROBIOLOGY OF AGING

IF3.5

2017-12-0125

OAAI

Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma

美金刚聚乙二醇化生物可降解纳米粒子治疗青光眼的研究

IF12.1

2017-11-2079

OA